1. Corporate Officers - V
2. Valantine Hannah

Insider Trading History of Valantine Hannah

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Valantine Hannah since 2023. This trader's CIK number is 1855608. At the time of last reporting, Valantine Hannah was the Officer of Bridgebio Pharma, Inc.. (stock ticker symbol BBIO). Also see all insider trading activities at Bridgebio Pharma, Inc..

Note that in the past Valantine Hannah also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Caredx, Inc. (CDNA) by Valantine Hannah

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	CDNA	0	$0	10,570	$202,563	0	$0

Yearly summary of insider trading at Bridgebio Pharma, Inc. (BBIO) by Valantine Hannah

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	BBIO	0	$0	21,874	$798,618	17,167	$287,547
2024	BBIO	0	$0	5,830	$220,723	5,830	$49,262
2023	BBIO	0	$0	2,915	$105,289	2,915	$24,631

Insider trading activities at 2 companies by Valantine Hannah:

1. Caredx, Inc. (CDNA)

2. Bridgebio Pharma, Inc. (BBIO)

Table 1. Insider trading of Caredx, Inc. (CDNA) by Valantine Hannah

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-06-18	CDNA	Sale	10,570	19.16	202,563

Table 2. Insider trading of Bridgebio Pharma, Inc. (BBIO) by Valantine Hannah

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-06-26	BBIO	Sale	4,707	44.07	207,432
2025-06-10	BBIO	Option Ex	4,292	16.75	71,891
2025-06-10	BBIO	Sale	4,292	40.00	171,680
2025-03-06	BBIO	Option Ex	12,875	16.75	215,656
2025-03-06	BBIO	Sale	12,875	32.58	419,506
2024-02-15	BBIO	Option Ex	2,915	8.45	24,631
2024-02-15	BBIO	Sale	2,915	37.75	110,041
2024-01-16	BBIO	Sale	2,915	37.97	110,682
2024-01-16	BBIO	Option Ex	2,915	8.45	24,631
2023-12-15	BBIO	Sale	2,915	36.12	105,289
2023-12-15	BBIO	Option Ex	2,915	8.45	24,631

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valantine Hannah (Officer of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month